600196 复星医药
2025/12 -
人民币(K¥)
与去年末期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)

非流动资产
长期股权投资26,371,6256.80%24,691,50123,919,39923,144,77122,683,713
投资性房地产0--0000
固定资产17,977,2713.41%17,385,19515,129,37110,267,8598,919,058
在建工程3,055,431-11.06%3,435,4514,938,2814,896,6973,617,705
无形资产13,999,154-3.24%14,468,39313,482,01612,471,05710,276,254
商誉10,809,757-0.87%10,905,08310,851,99910,337,0539,399,987
其他非流动资产14,020,05916.02%12,083,88411,355,96910,767,2927,972,697
86,233,2983.93%82,969,50779,677,03671,884,72962,869,415

流动资产
货币资金13,104,229-3.10%13,523,93313,693,59116,241,31310,317,224
应收账款9,364,52217.76%7,952,0737,643,7367,588,0996,029,720
存货6,252,472-13.86%7,258,6497,537,7686,882,4325,472,547
其他流动资产5,099,448-11.41%5,756,4064,917,4744,567,3338,617,416
33,820,671-1.94%34,491,06133,792,56935,279,17830,436,907

流动负债
短期借款15,529,940-17.00%18,711,31514,728,45411,931,5379,420,129
应付票据287,969-53.48%619,015652,252857,879548,388
应付帐款4,856,045-9.71%5,378,3705,507,3665,426,1624,515,305
其他流动负债15,750,36223.59%12,743,96912,869,51115,082,49114,834,650
36,424,316-2.75%37,452,66933,757,58433,298,06929,318,473
流动资产净值(2,603,645)-12.09%(2,961,609)34,9851,981,1091,118,435
资产总额减流动负债83,629,6534.53%80,007,89879,712,02173,865,83863,987,849

非流动负债
长期借款10,361,9911.55%10,203,50013,504,92311,600,4376,694,183
应付债券1,500,000525.00%240,0000499,4312,354,886
其他非流动负债9,927,3123.08%9,630,6699,590,8387,657,0606,559,212
21,789,3038.54%20,074,16923,095,76119,756,92815,608,281

总权益
    实收股本2,670,429-0.03%2,671,3262,672,3992,672,1572,562,899
    储备项目46,071,0783.32%44,589,78043,012,36341,910,30136,632,660
股东权益48,741,5073.13%47,261,10745,684,76244,582,45839,195,558
非控股权益13,098,8433.36%12,672,62210,931,4999,526,4529,184,010